Page last updated: 2024-10-20

pyridoxine and Hyperlipemia

pyridoxine has been researched along with Hyperlipemia in 12 studies

4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).

Research Excerpts

ExcerptRelevanceReference
"Hyperhomocysteinemia has been identified as a potential risk factor for atherosclerosis."7.70Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS) ( Beilby, JP; Hung, J; McQuillan, BM; Nidorf, M; Thompson, PL, 1999)
"Hyperhomocysteinemia has been identified as a potential risk factor for atherosclerosis."3.70Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS) ( Beilby, JP; Hung, J; McQuillan, BM; Nidorf, M; Thompson, PL, 1999)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19908 (66.67)18.7374
1990's3 (25.00)18.2507
2000's1 (8.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
KNUECHEL, F1
YASUGI, T1
Glueck, CJ1
Shaw, P1
Lang, JE1
Tracy, T1
Sieve-Smith, L1
Wang, Y1
McQuillan, BM1
Beilby, JP1
Nidorf, M1
Thompson, PL1
Hung, J1
Chait, A1
Malinow, MR1
Nevin, DN1
Morris, CD1
Eastgard, RL1
Kris-Etherton, P1
Pi-Sunyer, FX1
Oparil, S1
Resnick, LM1
Stern, JS1
Haynes, RB1
Hatton, DC1
Metz, JA1
Clark, S1
McMahon, M1
Holcomb, S1
Reusser, ME1
Snyder, GW1
McCarron, DA1
Dierkes, J1
Westphal, S1
Kunstmann, S1
Banditt, P1
Lössner, A1
Luley, C1
Snyderman, SE1
Lenzi, S1
Fourrier, A1
Mouton, Y1
Mirouze, J1
Orsetti, A1
Cartry, E1
Yamada, K1
Kuzuya, F1
Yokoyama, T1
Oguri, T1
Okura, Y1
Yoshimine, N1
Mizuno, S1
Kuno, K1
Kitagawa, M1
Quinton, A1

Reviews

2 reviews available for pyridoxine and Hyperlipemia

ArticleYear
[MECHANISM OF ACTION OF LIPEMIA-CLEARING PREPARATIONS].
    [Sogo rinsho] Clinic all-round, 1963, Volume: 12

    Topics: Dextrans; Edetic Acid; Heparin; Hyperlipidemias; Lipoprotein Lipase; Neomycin; Niacin; Nicotinic Aci

1963
The dietary therapy of inherited metabolic disease.
    Progress in food & nutrition science, 1975, Volume: 1, Issue:7-8

    Topics: Alkaptonuria; Amino Acid Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors; Child; C

1975

Trials

3 trials available for pyridoxine and Hyperlipemia

ArticleYear
Increased dietary micronutrients decrease serum homocysteine concentrations in patients at high risk of cardiovascular disease.
    The American journal of clinical nutrition, 1999, Volume: 70, Issue:5

    Topics: Adult; Aged; Analysis of Variance; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diet; Female;

1999
Vitamin supplementation can markedly reduce the homocysteine elevation induced by fenofibrate.
    Atherosclerosis, 2001, Volume: 158, Issue:1

    Topics: Cross-Over Studies; Double-Blind Method; Fenofibrate; Folic Acid; Homocysteine; Humans; Hyperlipidem

2001
[Clinical and biological study of a new vascular protective agent and hypolipemic agent, pyridoxine para-chloro-phénoxy-isobutyrate. (Claresan)].
    Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille, 1974, Volume: 19, Issue:4 Suppl 11

    Topics: Adult; Aged; Clinical Trials as Topic; Clofibrate; Diet, Reducing; Drug Tolerance; Female; Humans; H

1974

Other Studies

7 other studies available for pyridoxine and Hyperlipemia

ArticleYear
[Effect of Lipokapsul on the serum lipids in arteriosclerosis (with reference to different diet forms)].
    Die Medizinische Welt, 1962, Sep-01, Volume: 35

    Topics: Arteriosclerosis; Coronary Disease; Diet; Diet Therapy; Fatty Acids; Fatty Acids, Essential; Humans;

1962
Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients.
    The American journal of cardiology, 1995, Jan-15, Volume: 75, Issue:2

    Topics: Aged; Analysis of Variance; Arteriosclerosis; Coronary Disease; Cystathionine; Folic Acid; Homocyste

1995
Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS)
    Circulation, 1999, May-11, Volume: 99, Issue:18

    Topics: Adult; Aged; Amino Acid Substitution; Arteriosclerosis; Carotid Arteries; Carotid Stenosis; Comorbid

1999
[Drug therapy of dyslipidemias].
    Minerva medica, 1975, Oct-06, Volume: 66, Issue:66

    Topics: Anticholesteremic Agents; Bile Acids and Salts; Cholestyramine Resin; Clofibrate; Heparin; Humans; H

1975
[Pyridoxine para-chloro-phenoxy-isobutyrate. Analysis of hypolipidemic effects].
    La Nouvelle presse medicale, 1973, Volume: 2, Issue:46

    Topics: Clofibrate; Diabetes Mellitus; Diet; Drug Evaluation; Humans; Hyperlipidemias; Obesity; Pyridoxine;

1973
Effects of vitamin B6 and safflower oil on dietarily induced hyperlipemia and fat in the liver of rats.
    The Journal of vitaminology, 1965, Sep-10, Volume: 11, Issue:3

    Topics: Animals; Fatty Acids, Essential; Fatty Liver; Hyperlipidemias; Pyridoxine; Rats

1965
[Therapeutic actions of Pyridofylline in dyspnea, hyperlipemia and certain hepatobiliary diseases].
    Semaine therapeutique, 1966, Volume: 42, Issue:9

    Topics: Adult; Biliary Tract Diseases; Dyspnea; Female; Humans; Hyperlipidemias; Liver Diseases; Male; Pyrid

1966